A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

NCT04660643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

783

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Tirzepatide
OTHER: Placebo

Sponsor

Eli Lilly and Company